ADTRP: A Key Regulator of Androgen Signaling (G84830)

Target Name: ADTRP

NCBI ID: G84830

ADTRP

ADTRP: A Key Regulator of Androgen Signaling

Androgen-dependent TPF1-regulating protein (ADTRP) is a protein that plays a crucial role in the regulation of androgen signaling in the body. It is a key regulator of testosterone levels and has been implicated in various physiological processes, including sexual function, bone health, and muscle mass.

ADTRP is a protein that is expressed in various tissues throughout the body, including testes, ovaries, brain, heart, and skeletal muscles. It is a key regulator of androgen signaling and has been shown to play a role in the regulation of sexual function, including male and female reproductive organs, testosterone levels, and muscle mass.

ADTRP is a protein that is composed of several domains, including an N-terminus, a catalytic domain, and a C-terminus. The N-terminus of ADTRP contains a putative nuclear localization domain (NLD), which is known to play a role in the regulation of nuclear processes. The catalytic domain of ADTRP contains a catalytic core that is responsible for the protein's catalytic activity.

The C-terminus of ADTRP contains a regions that are involved in its interactions with other proteins. These regions include a zinc finger domain (ZFD), which is known to play a role in the regulation of protein stability and a leucinerich repeat (LRR) domain, which is known to play a role in the regulation of protein-protein interactions.

ADTRP is a protein that has been shown to play a role in the regulation of various physiological processes, including sexual function, bone health, and muscle mass. It is a key regulator of androgen signaling and has been shown to play a role in the regulation of male and female reproductive organs, testosterone levels, and muscle mass.

ADTRP is also a potential drug target or biomarker, due to its role in the regulation of androgen signaling and its potential to be modulated by various therapeutic approaches.

Drug Targets

ADTRP is a protein that is involved in androgen signaling and has been shown to play a role in the regulation of various physiological processes, including sexual function, bone health, and muscle mass. As such, it is a potential drug target or biomarker for various androgen-related conditions, including male and female reproductive disorders, bone loss, and muscle wasting.

One potential approach to targeting ADTRP is to use small molecules or antibodies that can modulate its activity. These molecules can be used to either activate or inhibit the activity of ADTRP, depending on its specific function in the body.

For example, one potential approach to targeting ADTRP is to use small molecules that can inhibit its activity as a regulator of androgen signaling. These molecules can be found in natural products, such as certain plants and animals, or can be synthesized using synthetic methods.

Another potential approach to targeting ADTRP is to use antibodies that recognize and bind to its specific domain(s). These antibodies can be used to either activate or inhibit the activity of ADTRP, depending on its specific function in the body.

BioMarkers

ADTRP is also a potential biomarker for various androgen-related conditions. Its expression and activity can be used to diagnose and monitor these conditions, including male and female reproductive disorders, bone loss, and muscle wasting.

For example, one potential approach to using ADTRP as a biomarker is to measure its expression and activity in various tissues or biological samples, such as testes, ovaries, bone marrow, or muscle tissue. These measurements can be used to determine the level of ADTRP expression and activity, which can then be used to diagnose or monitor various androgen-related conditions.

Conclusion

ADTRP is a protein that plays a crucial role in the regulation of androgen signaling in the body. It is a key regulator of testosterone levels and has been implicated in various physiological processes, including sexual function, bone health, and muscle mass.

ADTRP is also a potential drug target or biomarker, due to its role in the regulation of androgen signaling and its potential to be modulated by various therapeutic approaches. Further research is needed to fully understand the role of ADTRP in the regulation of androgen signaling and its potential as a drug target or biomarker.

Protein Name: Androgen Dependent TFPI Regulating Protein

Functions: Hydrolyzes bioactive fatty-acid esters of hydroxy-fatty acids (FAHFAs), but not other major classes of lipids (PubMed:27018888). Show a preference for FAHFAs with branching distal from the carboxylate head group of the lipids (PubMed:27018888). Regulates the expression and the cell-associated anticoagulant activity of the inhibitor TFPI in endothelial cells (in vitro) (PubMed:21868574)

The "ADTRP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADTRP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets